Our Perspectives

Our Perspectives published on December 13, 2019
The recent proliferation of patient and caregiver support programs is being driven by greater patient involvement in health decisions, increasing attention on patient outcomes, and the growth of specialty drugs that require additional patient support. These programs encompass a range of services which enable pharmaceutical companies to improve access to, usage of, and adherence to prescription drug treatments.
Our Perspectives published on December 13, 2019
For decades, pharmaceutical companies have consulted with key healthcare providers (HCPs) and other key opinion leaders who have their finger on the pulse of the treatment landscape. In face-to-face interactions, HCPs have provided insight into a wide range of subjects related to a product or disease state.
Our Perspectives published on December 13, 2019
Each year, between 700,000 and 900,000 medical journal articles are added to the PubMed database managed by The U.S. National Library of Medicine. Many of these articles focus on key findings from biopharmaceutical research, conducted by companies that invest more than $70 billion annually in research and development of new therapies.

Results 1 - 3 of 3
 1249 South River Road, Suite 202A, Cranbury, NJ 08512
© The Lynx Group, LLC. All Rights Reserved.